Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

AHRQ Soliciting Comments on Pain Management Injections for Low Back Pain

Monday, February 24, 2014


The Agency for Healthcare Research and Quality (AHRQ) is soliciting feedback to a series of questions that will help the Agency assess the clinical utility of pain management injections for low back pain.  As part of AHRQ’s Technology Assessment Program, this information could be used by the Centers for Medicare and Medicaid Services to inform its national coverage decisions for the Medicare program as well as provide information to Medicare contractors.  Comments will be accepted until March 3, 2014. 

Submit comments to AHRQ.

Learn more about the Technology Assessment Program.  

Read AHRQ’s Topic Refinement Document on Pain Management Injection Therapies for Low-back Pain.


« Back to Washington Alerts